Share
6,849 Posts.
lightbulb Created with Sketch. 383
clock Created with Sketch. 28/06/25
13:25
Share
Originally posted by Ladytradr:
↑
Potential opportunity size greater than PKD in B* unrisked modellingPYC’s renal program in Polycystic kidney disease (PKD) supports ~50% of PT today, but when looking at our unrisked valuation ($18/sh assuming 100% probability of success for all programs) PMS reflects a greater opportunity vs PKD (B*e $3.5b EV vs $3.1b EV respectively).
Expand
I can see that the potential for a leap in share price has now got closer. And the leap bigger.
(20min delay)